Evaluation of pooled rapid HIV antibody screening of patients admitted to a San Diego Hospital

Journal of Virological Methods

Volumn 174, Issue 1-2, 2011, Pages 94-98

  Mehta, Sanjay R ^a   Nguyen, Vu T ^a   Osorio, Georgina ^a   Little, Susan ^a   Smith, Davey M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Cost effective screening; HIV screening; Pooled testing; Rapid antibody testing

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANALYTICAL EQUIPMENT; ANTIBODY DETECTION; ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; HEALTH CARE COST; HIV TEST; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; OPTICAL DENSITY; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADOLESCENT; ADULT; CALIFORNIA; DIAGNOSTIC TESTS, ROUTINE; FALSE NEGATIVE REACTIONS; HIV ANTIBODIES; HIV INFECTIONS; HOSPITALS; HUMANS; MASS SCREENING; MIDDLE AGED; PREVALENCE; SENSITIVITY AND SPECIFICITY; VIROLOGY; YOUNG ADULT;

EID: 79955749467     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.04.002     Document Type: Article

References (28)

1. Branson B.M., Handsfield H.H., Lampe M.A., Janssen R.S., Taylor A.W., Lyss S.B., Clark J.E. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm. Rep. 2006, 55:1-17. quiz CE1-4.
2. Campsmith M.L., Rhodes P.H., Hall H.I., Green T.A. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J. Acquir. Immune Defic. Syndr. 2009, 53:619-624.
3. Delaney K.P., Branson B.M., Uniyal A., Phillips S., Candal D., Owen S.M., Kerndt P.R. Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin. Infect. Dis. 2004, 52:257-263.
4. Dorfman R. The detection of defective members of large populations. Ann. Math. Stat. 1943, 14:436-440.
5. Eisele T.P., Mathews C., Chopra M., Lurie M.N., Brown L., Dewing S., Kendall C. Changes in risk behavior among HIV-positive patients during their first year of antiretroviral therapy in Cape Town South Africa. AIDS Behav. 2009, 13:1097-1105.
6. Granich R.M., Gilks C.F., Dye C., De Cock K.M., Williams B.G. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009, 373:48-57.
7. Janssen R.S., Satten G.A., Stramer S.L., Rawal B.D., O'Brien T.R., Weiblen B.J., Hecht F.M., Jack N., Cleghorn F.R., Kahn J.O., Chesney M.A., Busch M.P. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998, 280:42-48.
8. Kalichman S.C., Rompa D., Cage M. Group intervention to reduce HIV transmission risk behavior among persons living with HIV/AIDS. Behav. Modif. 2005, 29:256-285.
9. Kamb M.L., Fishbein M., Douglas J.M., Rhodes F., Rogers J., Bolan G., Zenilman J., Hoxworth T., Malotte C.K., Iatesta M., Kent C., Lentz A., Graziano S., Byers R.H., Peterman T.A. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA 1998, 280:1161-1167.
10. Killian M.S., Norris P.J., Rawal B.D., Lebedeva M., Hecht F.M., Levy J.A., Busch M.P. The effects of early antiretroviral therapy and its discontinuation on the HIV-specific antibody response. AIDS Res. Hum. Retroviruses 2006, 22:640-647.
11. Lyamuya E.F., Aboud S., Urassa W.K., Sufi J., Mbwana J., Ndugulile F., Massambu C. Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. BMC Infect. Dis. 2009, 9:19.
12. Marks G., Crepaz N., Senterfitt J.W., Janssen R.S. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J. Acquir. Immune Defic. Syndr. 2005, 39:446-453.
13. Morris S.R., Little S.J., Cunningham T., Garfein R.S., Richman D.D., Smith D.M. Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann. Intern. Med. 2010, 152:778-785.
14. Novack L., Galai N., Yaari A., Orgel M., Shinar E., Sarov B. Use of seroconversion panels to estimate delay in detection of anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay of pooled compared to singleton serum samples. J. Clin. Microbiol. 2006, 44:2909-2913.
15. OraSure OraQuick Rapid HIV-1 Antibody Test 2004, OraSure, Bethlehem. O.T. Inc. (Ed.).
16. Owen S.M., Yang C., Spira T., Ou C.Y., Pau C.P., Parekh B.S., Candal D., Kuehl D., Kennedy M.S., Rudolph D., Luo W., Delatorre N., Masciotra S., Kalish M.L., Cowart F., Barnett T., Lal R., McDougal J.S. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J. Clin. Microbiol. 2008, 46:1588-1595.
17. Pilcher C.D., Fiscus S.A., Nguyen T.Q., Foust E., Wolf L., Williams D., Ashby R., O'Dowd J.O., McPherson J.T., Stalzer B., Hightow L., Miller W.C., Eron J.J., Cohen M.S., Leone P.A. Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med. 2005, 352:1873-1883.
18. Pinkerton S.D., Bogart L.M., Howerton D., Snyder S., Becker K., Asch S.M. Cost of OraQuick oral fluid rapid HIV testing at 35 community clinics and community-based organizations in the USA. AIDS Care 2009, 21:1157-1162.
19. Roth W.K., Weber M., Buhr S., Drosten C., Weichert W., Sireis W., Hedges D., Seifried E. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion 2002, 42:862-868.
20. Sanders G.D., Bayoumi A.M., Sundaram V., Bilir S.P., Neukermans C.P., Rydzak C.E., Douglass L.R., Lazzeroni L.C., Holodniy M., Owens D.K. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N. Engl. J. Med. 2005, 352:570-585.
21. Sherlock M., Zetola N.M., Klausner J.D. Routine detection of acute HIV infection through RNA pooling: survey of current practice in the United States. Sex Transm. Dis. 2007, 34:314-316.
22. Smith D.M., May S.J., Perez-Santiago J., Strain M.C., Ignacio C.C., Haubrich R.H., Richman D.D., Benson C.A., Little S.J. The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS 2009, 23:2151-2158.
23. Soroka S.D., Granade T.C., Phillips S., Parekh B. The use of simple, rapid tests to detect antibodies to human immunodeficiency virus types 1 and 2 in pooled serum specimens. J. Clin. Virol. 2003, 27:90-96.
24. Stekler J.D., Swenson P.D., Coombs R.W., Dragavon J., Thomas K.K., Brennan C.A., Devare S.G., Wood R.W., Golden M.R. HIV testing in a high-incidence population: is antibody testing alone good enough?. Clin. Infect. Dis. 2009, 49:444-453.
25. Sweat M., Gregorich S., Sangiwa G., Furlonge C., Balmer D., Kamenga C., Grinstead O., Coates T. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000, 356:113-121.
26. Urassa W., Nozohoor S., Jaffer S., Karama K., Mhalu F., Biberfeld G. Evaluation of an alternative confirmatory strategy for the diagnosis of HIV infection in Dar Es Salaam, Tanzania, based on simple rapid assays. J. Virol. Methods 2002, 100:115-120.
27. Weinhardt L.S., Carey M.P., Johnson B.T., Bickham N.L. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am. J. Public Health 1999, 89:1397-1405.
28. Westreich D.J., Hudgens M.G., Fiscus S.A., Pilcher C.D. Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. J. Clin. Microbiol. 2008, 46:1785-1792.